Tempus, a leader in artificial intelligence and precision medicine, will present new data along with Pfizer at the AACR 2024 Annual Meeting. The abstract,...
Tempus, a leader in artificial intelligence and precision medicine, is broadly introducing its new Workspaces feature in the Lens platform. Workspaces is a private,...
Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic outcomes, will showcase its...
Collaboration combines expertise in computational chemistry, artificial intelligence and machine learning, to help advance discovery and development of medicines for difficult-to-drug targets
Odyssey Therapeutics, Inc.,...
Anivive Lifesciences, is set to unveil groundbreaking research at the upcoming World Vaccine Congress, where they will present findings on the development of the world's...
Manifold, an AI-powered clinical research platform, announced a $15 million Series A. Led by TQ Ventures, the funding round also includes new investors Calibrate Ventures...
PhenoScope can cut drug development time and costs significantly, while delivering safer & more effective therapy for cancer patients
SimBioSys, a leading innovator in precision...
Aurigene Pharmaceutical Services Limited , a contract research, development, and manufacturing services organization and a Dr. Reddy’s Laboratories company, introduces Aurigene.AI, an AI and...
Ultivue, a market leader in quantitative proteomic biomarker detection and advanced spatial tissue profiling, is unveiling its spatial insights platform, STARVUE™, at the American...
X-Chem, the leading provider of innovative solutions in early-stage drug discovery, announced the addition of Dr. Erin Davis as chief technology officer. Dr. Davis...